Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.

Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer. Int J Gynecol Cancer. 2008 Mar-Apr; 18(2):262-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.